Medivolve Signs Agreement to Acquire 100% of Modern Rx LCC, a Las Vegas based Pharmacy
03/16/2021 | 06:31am EDT
Send by mail :
Message :
TORONTO, March 16, 2021 (GLOBE NEWSWIRE)
Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the signing of a binding Letter of Intent (LOI) to acquire a 100% equity interest in Modern Rx LLC, a Las Vegas based pharmacy from shareholders of Modern. This pharmacy is expected to serve as an important component of Medivolve’s telehealth strategy, where Collection Sites telehealth patients will be able to have their presecription filled directly through the pharmacy’s operating license.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement
Medivolve Inc.February 19, 2021 GMT
TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the cancellation of the agreement to acquire 100% of Karland Health, LLC. As noted in the initial press release dated February 11th, 2021, the completion of the transaction to acquire Karland Health was subject to customary closing conditions, including due diligence to the satisfaction of Medivolve. After completing further due diligence, management determined that the acquisition of Karland Health would not be sufficiently accretive for the Company.
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medivolve Announces Launch of Investor Awareness Campaign
Medivolve Inc.February 18, 2021 GMT
TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of an investor marketing campaign to increase awareness for the Company’s strong operational results and its strategic decision to enter the telehealth and remote patient monitoring market. The Company has allocated this budget for digital marketing given current state of affairs; the Company cannot attend tradeshows, sponsor events, or travel for roadshows in the same capacity it could pre-pandemic, and hence, has allocated these budgets to digital efforts to ensure the company does not suffer due to lack of market awareness. The awareness campaign will include marketing services from the below groups at the set-out terms.
Medivolve Also Strengthens its Balance Sheet via Shares for Debt SettlementsTORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce that it has signed a binding letter of intent to acquire 100% of Karland Health, LLC. In 2020, Medivolve’s wholly owned subsidiary, Collection Sites LLC, launched COVID-19 testing services in conjunction with Alcala Testing and Analysis Services, a CLIA registered high complexity laboratory based in San Diego, California. Collection Sites opened their first testing location on August 8, 2020 and has grown substantially since with January tests conducted of 73,973 at an average price of US$96 per test. Appointments and payments are handled through an online portal www.testbeforeyougo.com. Under the terms set out in the agreement, Medivolve is to issue a total of 20 million Medivolve common shares to the shareholders of Karland Health in e